EMCDDA news
Methamphetamine from Afghanistan: ‘signals indicate that Europe should be better prepared’, says new EMCDDA report
This report was prepared before recent developments in Afghanistan and before the withdrawal of US military and other NATO allies from the country. The findings of this report are preliminary and will need to be reviewed and updated as more information becomes available from the region.
29.09.2021
Čtěte více
Green light for two-year work programme on bilateral cooperation with Georgia
A two-year work programme on bilateral cooperation with Georgia was agreed upon today at the first advisory committee meeting of the EMCDDA4Georgia project, hosted virtually by the agency. Launched on 3 May this year, the project aims to enhance national responses to drug-related health and security threats and focuses primarily on knowledge transfer and capacity-building in the areas of drug monitoring, reporting, prevention and treatment.
28.09.2021
Čtěte více
Implementing quality standards for drug services and systems: a six-step guide to support quality assurance
Six steps to improve the quality of drug services and systems — EMCDDA launches new practical manual for decision-makers
Six steps to help improve the quality of drug services and systems in Europe are presented today in a new manual from the EU drugs agency (EMCDDA). Entitled Implementing quality standards for drug services and systems: a six-step guide to support quality assurance, the publication offers practical advice for professionals implementing quality assurance in the area of drug demand reduction.
27.09.2021
Čtěte více
In memoriam — His Excellency Dr Jorge Sampaio
It was with great sadness that the EMCDDA learned today of the passing of His Excellency Dr Jorge Sampaio, former President of the Portuguese Republic.
10.09.2021
Čtěte více
Synthetic cannabinoids in Europe – a review
New report highlights public health and social risks posed by synthetic cannabinoids in Europe
Synthetic cannabinoids come under the spotlight today in a new report released by the EU drugs agency (EMCDDA). Widely available across Europe and highly potent, these substances are placing some users at a ‘high risk of poisoning’, the agency warns.
09.09.2021
Čtěte více
EMCDDA expert meeting on digital health innovation
Recent EMCDDA studies on the impact of COVID-19 containment measures on drug services in Europe highlighted the rapid and widespread adoption of telemedicine and online communication. In some countries, core drug treatment modalities moved online and virtual technologies were used to support more conventional treatment approaches. In line with these developments, the EMCDDA is hosting an expert meeting today dedicated to digital health innovation.
03.09.2021
Čtěte více
